Design Therapeutics Inc
Ownership
Ownership Structure
Who owns Design Therapeutics Inc (DSGN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 57.8% of the shares are freely tradable; institutional investors hold 62.1%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 10.43 | 6,526,476 | +0.0 | 06/30/2026 |
| Logos Global Management LP | 4.79 | 3,000,000 | +53.8 | 06/30/2026 |
| Baker Bros Advisors LP | 4.28 | 2,678,430 | +3.6 | 06/30/2026 |
| Driehaus Capital Management LLC | 4.25 | 2,661,115 | +52.5 | 06/30/2026 |
| BlackRock Inc | 4.25 | 2,660,024 | +24.7 | 06/30/2026 |
| Point72 Asset Management, L.P. | 3.78 | 2,366,453 | -13.1 | 06/30/2026 |
| Trails Edge Capital Partners, LP | 3.20 | 2,001,282 | +134.9 | 06/30/2026 |
| Frazier Life Sciences Management, L.P. | 2.89 | 1,809,854 | +0.0 | 06/30/2026 |
| Vivo Capital, LLC | 2.58 | 1,612,903 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 2.51 | 1,571,022 | +16.4 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.